DARBY PASCHALL: Open Payments
NPI 1952056517 · VERSAILLES, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 67 payments from 12 companies in 2025. Trend: 2023 $63 · 2024 $450 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Indivior Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Grifols USA, LLC | 1 | $29 |
| Corcept Therapeutics | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, GLASSIA, Auvelity, Prolastin-C Liquid, ARALAST, MAVYRET.
Industry payments across KY — which companies pay providers there.
